12 newly identified AD-associated genes show prior evidence linking them to neurofibrillary tangles or phosphorylated tau, with differential transcriptomic or proteomic expression between AD and healt

Computational Score: 0.500 Price: $0.50 Alzheimer's disease in_vitro Status: extracted

What This Experiment Tests

Computational experiment designed to assess clinical efficacy targeting PCDH9, NRG3, ROR1, LINGO2, SMYD3, LRRC7 in in_vitro. Primary outcome: 12 newly identified AD-associated genes show prior evidence linking them to neurofibrillary tangles

Description

Post hoc analysis of previously published differential expression data in AD brain tissue

TARGET GENE
PCDH9, NRG3, ROR1, LINGO2, SMYD3, LRRC7
MODEL SYSTEM
in_vitro
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
neurofibrillary tangle formation, tau phosphorylation
SOURCE
pmid_39775791
PRIMARY OUTCOME
12 newly identified AD-associated genes show prior evidence linking them to neurofibrillary tangles or phosphorylated tau, with differential transcriptomic or proteomic expression between AD and healthy brains for 10 of these genes.

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.500 composite

Related Hypotheses (1)

Tau-trafficking GWAS loci define a druggable PTK2B endocytosis-kinase axis in AD0.600

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.